Abstract
Since 1978 an automated chromogenic method for ant ¡thrombin III (AT III) has been applied in various clinical situations in our laboratory (1).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Kahlé LH, Schipper HG, Jenkins CSP, and Ten Cate JW. 1979. An automated method for the determination of antithrombin I I I activity. Thromb.Res. 2, 1003–1014.
Abildgaard U. 1979. Evidence that antithrombin III is the main physiological inhibitor of coagulation enzymes. In: The physiological inhibitors of blood coagulation and fibrinolysis, Collen D, Wiman B, and Verstraete M (Eds.), Elsevier/North-Hol land, Biomedical Press, pp 31–33.
Egeberg O. 1965. Inherited antithrombin deficiency causing thrombophilia. Thromb. Diath. Haemorrh. 13, 516–530.
Sas G, Blaskö G, Bänhegyi D, Jäkö J, and Pälos LA. 1974. Ab¬normal antithrombin III ( Antithrombin III “Budapest”) as a cause of familial thrombophilia. Thromb.Diath.Haemorrh. 32, 105–115.
Schipper HG, Roos J, V.d. Meulen F, and Ten Cate JW. 1980. Antithrombin III deficiency in surgical intensive care patients. Submitted for publication.
Tanaka H, Kobayashi N, Takeuchi T, Takada M, and Malkawa T. 1979. Effect of endotoxin on kinetics of antithrombin III. Thromb.Haemostas. 42, 374.
Büller HR, Weenink AH, Treffers PE, Kahle LH, Otten HA, and Ten Cate JW. 1980. Severe antithrombin III deficiency in a patient with pre-ecclampsia. Scand.J.Haemat. In Press.
Weenink HG, Treffers PE, and Ten Cate JW. 1980. AT III and oral contraceptive therapy. Submitted for publication.
Tytgat GN, Collen D, and Verstraete M. 1971. Metabolism of fibrinogen in cirrhosis of the liver. J.C I i n. I nvest. 50, 1690–1701.
Collen D, Rouvier J, Chamone DAF, and Verstraete M. 1978. Turnover of radiolabeled plasminogen and prothrombin in cirrhosis of the liver. Eur. J.CI in. I nvest. 8, 185–195.
Schipper HG and Ten Cate JW. 1980. Antithrombin III transfusion in patients with liver cirrhosis. In: Thesis, University of Amsterdam, Schipper HG: Antithrombin III and human antithrombin III concentrates, pp 65–85.
Giles AR, Sauder D, Seaton TL, Johnston M, and Hirsh J. 1977. Changes in the coagulation status of patients undergoing auto- transfusion of concentrated ascitic fluid as treatment of refractory ascites. Blood 50, 267.
Kauffmann RH, De Graeff J, and Brutel de la Riviere G. 1976. Unilateral thrombosis and nephrotic syndrome. Am.J.Med. 60, 1048–1054.
Kauffman.n. RH, Veitkamp JJ, Van Tilburg NH, and Van Es LA. 1978. Acquired antithrombin III deficiency and thrombosis in the nephrotic syndrome. Am.J.Med. 65, 607–613.
Thaler E, Balzar E, Kopsa H, and Pinggera WF. 1978. Acquired antithrombin III deficiency in patients with glomular proteinuria. Haemostasis 7, 257–272.
Jørgensen KA and Stoffersen E. 1979. Antithrombin I I I and the nephrotic syndrome. Scand.J.Haematol. 22, 442–448.
Marciniak E and Gockerman JP. 1977. Heparin-induced decrease in circulating antithrombin III. Lancet 2, 581–584.
Kakkar VV, Bentley PG, Scully MF, MacGregor IR, Jones NAG, and Webb PJ. 1980. Antithrombin III and heparin. Lancet 1, 103–104.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Martinus Nijhoff Publishers bv, The Hague
About this chapter
Cite this chapter
Ten Cate, J.W. (1980). An Automated Chromogenic Antithrombin III Method : Clinical Experience. In: Lijnen, H.R., Collen, D., Verstraete, M. (eds) Synthetic Substrates in Clinical Blood Coagulation Assays. Developments in Hematology, vol 1. Springer, Dordrecht. https://doi.org/10.1007/978-94-009-8910-8_5
Download citation
DOI: https://doi.org/10.1007/978-94-009-8910-8_5
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-009-8912-2
Online ISBN: 978-94-009-8910-8
eBook Packages: Springer Book Archive